Test Price
2,800 AED✅ Home Collection Available
F9 Gene Thrombophilia (X‑linked, Factor IX Defect) Genetic Test in UAE
2800 AED
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited processing and ACMG‑aligned interpretation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test consultation to explain variant significance.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced Next‑Generation Sequencing test examines the entire coding region of the F9 gene to identify gain‑of‑function variants that drive X‑linked thrombophilia, a hereditary hypercoagulable state. The analysis provides high-resolution detection of single nucleotide variants, indels, and copy number changes with 200× mean coverage, classified according to ACMG/AMP guidelines.
| Feature | Our Test – NGS Full Gene | Closest Alternative – Factor IX Activity Assay |
|---|---|---|
| Precision | 99.9% analytical sensitivity for single nucleotide variants, indels, and copy number changes | Phenotypic; cannot distinguish mutation type or confirm carrier status |
| Methodology | NGS with 200× mean coverage, ACMG/AMP variant classification | Clotting‑based or chromogenic assay; does not identify DNA variant |
| Turnaround / Cost | 3–4 weeks | 2800 AED | 1–3 days | ≈ 600–900 AED (limited to functional screening) |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize that this test identifies inherited thrombophilia risk, not an acute diagnosis. A positive result must be interpreted alongside family history and clinical presentation. Genetic counselling is essential to understand the implications and to guide preventive management. Never alter prescribed anticoagulation therapy without consulting your specialist.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Exclusion Criteria & Red Flags
- Exclusion: Unstable clinical condition (acute thrombosis or haemorrhage) – prioritise urgent medical care.
- Exclusion: Individuals unable to provide informed consent or attend genetic counselling.
- ER Red Flag: Sudden severe chest pain, dyspnoea, or limb swelling → seek emergency care immediately; this test is not for acute diagnosis.
- Medication Warning (bold clinical notice): Do not discontinue prescribed medication without consulting your doctor.
Patient FAQ & Clinical Guidance
1. What does a positive F9 gene thrombophilia test mean for my health?
Direct clinical answer: A positive result indicates you carry a DNA variant that increases lifelong venous thromboembolism risk, requiring personalised prevention and regular monitoring with a haematologist or genetic specialist.
2. Is this test suitable for family screening and paediatric patients in the UAE?
Direct clinical answer: Yes, carrier and predictive testing in minors is permitted under UAE law but requires prior genetic counselling and guardian consent. We facilitate a dedicated paediatric counselling session before sample collection.
3. How should I prepare for the blood draw and genetic counselling session?
Direct clinical answer: Fasting is not required. Please bring a detailed three‑generation family history, any previous clotting test results, and a list of current medications. Our mobile phlebotomist will collect a standard peripheral blood sample at your preferred location.
UAE Regulatory & Data Privacy Adherence
This service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed under ISO 9001:2015 certified protocols (Cert: INT/EGQ/2509DA/3139) and stored in secure, encrypted systems. Patient consent for genetic testing is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | F9 Gene Thrombophilia (X‑linked, Factor IX Defect) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next-Generation Sequencing (NGS), 200× mean coverage |
| ICD-10-CM Code | D68.5 |
| LOINC Code | 35071-4 |
| DHA Facility License & Laboratory Address | DHA Facility License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians